Solid Biosciences Inc. (SLDB) stock
SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$6.35+0.12 (+1.93%)
Close on Nov 18, 2026Market cap $680.88MP/E –Yield –
Solid Biosciences cash
Cash and short-term investments held at the end of each period.
Solid Biosciences's cash was $377.70M at Jun 30, 2026. For fiscal 2025 it was $187.90M, up 26.2% from the year before. Over ten years it grew 20.7% a year on average. The highest annual figure on record is $213.72M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $187.90M | +26.2% |
| FY2024 | Dec 31, 2024 | $148.90M | +20.4% |
| FY2023 | Dec 31, 2023 | $123.64M | -42.1% |
| FY2022 | Dec 31, 2022 | $213.72M | +2.9% |
| FY2021 | Dec 31, 2021 | $207.78M | +34.0% |
| FY2020 | Dec 31, 2020 | $155.07M | +85.7% |
| FY2019 | Dec 31, 2019 | $83.52M | -31.8% |
| FY2018 | Dec 31, 2018 | $122.46M | +77.1% |
| FY2017 | Dec 31, 2017 | $69.16M | +781.8% |
| FY2016 | Dec 31, 2016 | $7.84M | -72.6% |
| FY2015 | Dec 31, 2015 | $28.60M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $377.70M | +40.9% |
| Q1 FY2026 | Mar 31, 2026 | $380.70M | +24.0% |
| Q4 FY2025 | Dec 31, 2025 | $187.90M | +26.2% |
| Q3 FY2025 | Sep 30, 2025 | $236.10M | +38.0% |
| Q2 FY2025 | Jun 30, 2025 | $268.10M | +40.9% |
| Q1 FY2025 | Mar 31, 2025 | $306.90M | +48.9% |
| Q4 FY2024 | Dec 31, 2024 | $148.90M | +20.4% |
| Q3 FY2024 | Sep 30, 2024 | $171.10M | +19.7% |
| Q2 FY2024 | Jun 30, 2024 | $190.30M | +18.8% |
| Q1 FY2024 | Mar 31, 2024 | $206.10M | +11.1% |
| Q4 FY2023 | Dec 31, 2023 | $123.64M | -42.1% |
| Q3 FY2023 | Sep 30, 2023 | $142.88M | +0.5% |
| Q2 FY2023 | Jun 30, 2023 | $160.19M | -1.7% |
| Q1 FY2023 | Mar 31, 2023 | $185.51M | +3.0% |
| Q4 FY2022 | Dec 31, 2022 | $213.72M | +2.9% |
| Q3 FY2022 | Sep 30, 2022 | $142.16M | -38.1% |
| Q2 FY2022 | Jun 30, 2022 | $162.88M | -34.6% |
| Q1 FY2022 | Mar 31, 2022 | $180.05M | -32.9% |
| Q4 FY2021 | Dec 31, 2021 | $207.78M | +34.0% |
| Q3 FY2021 | Sep 30, 2021 | $229.76M | +826.6% |
| Q2 FY2021 | Jun 30, 2021 | $248.96M | +510.7% |
| Q1 FY2021 | Mar 31, 2021 | $268.50M | +401.0% |
| Q4 FY2020 | Dec 31, 2020 | $155.07M | +85.7% |
| Q3 FY2020 | Sep 30, 2020 | $24.80M | -76.5% |
| Q2 FY2020 | Jun 30, 2020 | $40.77M | -39.5% |
| Q1 FY2020 | Mar 31, 2020 | $53.59M | -43.4% |
| Q4 FY2019 | Dec 31, 2019 | $83.52M | -31.8% |
| Q3 FY2019 | Sep 30, 2019 | $105.66M | -27.3% |
| Q2 FY2019 | Jun 30, 2019 | $67.39M | -58.6% |
| Q1 FY2019 | Mar 31, 2019 | $94.74M | -48.1% |
| Q4 FY2018 | Dec 31, 2018 | $122.46M | +77.1% |
| Q3 FY2018 | Sep 30, 2018 | $145.37M | +868.0% |
| Q2 FY2018 | Jun 30, 2018 | $162.76M | +397.5% |
| Q1 FY2018 | Mar 31, 2018 | $182.38M | +523.2% |
| Q4 FY2017 | Dec 31, 2017 | $69.16M | +781.8% |
| Q3 FY2017 | Sep 30, 2017 | $15.02M | -47.5% |
| Q2 FY2017 | Jun 30, 2017 | $32.72M | – |
| Q1 FY2017 | Mar 31, 2017 | $29.27M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.84M | – |
| Q4 FY2015 | Dec 31, 2015 | $28.60M | – |
See a number that looks wrong?